CardioDx Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
156
- Latest Deal Type
-
Out of Business
CardioDx General Information
Description
CardioDx Inc was incorporated in Delaware in July 2003. The Company is a molecular diagnostics company developing and commercializing novel, proprietary tests that help improve treatment decisions, enhance patient outcomes and reduce the overall cost of care. It uses genomic technologies to provide healthcare professionals with critical, actionable information to improve patient care and management. It focuses on diagnostics for cardiovascular diseases, such as coronary artery diseases, or CAD, arrhythmia and heart failure. Its Corus CAD test is a blood-based gene expression test that provides a current-state assessment for non-diabetic patients with symptoms that are suggestive of obstructive CAD.
Contact Information
Website
www.cardiodx.comCorporate Office
- 600 Saginaw Drive
- Redwood City, CA 94063
- United States
Corporate Office
- 600 Saginaw Drive
- Redwood City, CA 94063
- United States
CardioDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 09-Jan-2019 | Completed | Out of Business | |||
| 12. Later Stage VC (Series 1) | 17-Jan-2017 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series DD) | 22-Feb-2016 | Completed | Generating Revenue | |||
| 10. Debt - General | 01-Sep-2015 | Completed | Generating Revenue | |||
| 9. Mezzanine | 18-Jun-2015 | Completed | Generating Revenue | |||
| 8. IPO | 23-Dec-2014 | Cancelled | Generating Revenue | |||
| 7. Later Stage VC (Series DD) | 18-Dec-2014 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series CC) | 27-Aug-2012 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series BB) | 11-May-2011 | $60M | $140M | Completed | Generating Revenue | |
| 4. Later Stage VC (Series D) | 13-May-2010 | $35M | $79.9M | Completed | Generating Revenue |
CardioDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 1B | ||||||||
| Series 1A |
CardioDx Comparisons
Industry
Financing
Details
CardioDx Competitors (31)
One of CardioDx’s 31 competitors is Accuray, a Formerly VC-backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Accuray | Formerly VC-backed | Madison, WI | ||||
| NeuroLogica | Formerly VC-backed | Danvers, MA | ||||
| Avvio Medical | Venture Capital-Backed | San Francisco, CA | ||||
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| NalaGenetics | Venture Capital-Backed | Singapore, Singapore |
CardioDx Patents
CardioDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018160548-A1 | Markers for coronary artery disease and uses thereof | Inactive | 28-Feb-2017 | ||
| CA-2996191-A1 | Markers for coronary artery disease and uses thereof | Inactive | 01-Sep-2015 | ||
| EP-3344986-A1 | Markers for coronary artery disease and uses thereof | Inactive | 01-Sep-2015 | ||
| EP-3344986-A4 | Markers for coronary artery disease and uses thereof | Inactive | 01-Sep-2015 | ||
| US-20180356432-A1 | Markers for coronary artery disease and uses thereof | Inactive | 01-Sep-2015 | G01N33/6893 |
CardioDx Signals
CardioDx FAQs
-
When was CardioDx founded?
CardioDx was founded in 2004.
-
Where is CardioDx headquartered?
CardioDx is headquartered in Redwood City, CA.
-
What is the size of CardioDx?
CardioDx has 156 total employees.
-
What industry is CardioDx in?
CardioDx’s primary industry is Other Devices and Supplies.
-
Is CardioDx a private or public company?
CardioDx is a Private company.
-
What is CardioDx’s current revenue?
The current revenue for CardioDx is .
-
How much funding has CardioDx raised over time?
CardioDx has raised $324M.
-
Who are CardioDx’s competitors?
Accuray, NeuroLogica, Avvio Medical, Myriad Genetics, and NalaGenetics are some of the 31 competitors of CardioDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process